Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Unity Biotechnology Inc (NASDAQ: UBX)

 
UBX Technical Analysis
5
As on 12th May 2025 UBX SHARE Price closed @ 0.90 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.60 & Strong Sell for SHORT-TERM with Stoploss of 1.82 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

UBXSHARE Price

Open 0.95 Change Price %
High 0.95 1 Day -0.01 -1.10
Low 0.87 1 Week -0.20 -18.18
Close 0.90 1 Month -0.24 -21.05
Volume 175979 1 Year -1.23 -57.75
52 Week High 2.57 | 52 Week Low 0.88
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
TAOP 0.30 87.50%
GNLN 0.01 0.00%
NVDA 123.00 5.44%
PLUG 0.90 4.65%
LCID 2.62 4.38%
DUO 0.25 8.70%
LMDX 0.02 0.00%
TSLA 318.38 6.75%
CTMX 2.13 129.03%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
CYCC 3.59 1336.00%
REDU 3.41 1075.86%
ALZN 5.15 680.30%
CTXRW 0.14 600.00%
SRAX 0.38 533.33%
PXSAW 0.05 400.00%
NDRAW 0.03 200.00%
GLSPT 33.43 138.62%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
TBIO 0.01 -83.33%
NBSTU 2.00 -82.44%
ZWZZT 10.00 -75.50%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
TFFP 0.06 -62.50%
 
 
UBX
Daily Charts		 UBX
Intraday Charts		 Whats New @
Bazaartrend		 UBX
Free Analysis
 
UBX Important Levels Intraday
RESISTANCE1.05
RESISTANCE1.00
RESISTANCE0.97
RESISTANCE0.94
SUPPORT0.86
SUPPORT0.83
SUPPORT0.80
SUPPORT0.75
 
UBX Forecast May 2025
Share
4th UP Forecast1.88
3rd UP Forecast1.57
2nd UP Forecast1.37
1st UP Forecast1.18
1st DOWN Forecast0.62
2nd DOWN Forecast0.43
3rd DOWN Forecast0.23
4th DOWN Forecast-0.08
 
UBX Weekly Forecast
4th UP Forecast1.59
3rd UP Forecast1.37
2nd UP Forecast1.23
1st UP Forecast1.10
1st DOWN Forecast0.70
2nd DOWN Forecast0.57
3rd DOWN Forecast0.43
4th DOWN Forecast0.21
 
UBX Forecast2025
4th UP Forecast5.24
3rd UP Forecast3.85
2nd UP Forecast2.99
1st UP Forecast2.13
1st DOWN Forecast-0.33
2nd DOWN Forecast-1.19
3rd DOWN Forecast-2.05
4th DOWN Forecast-3.44
 
 
UBX Other Details
Segment EQ
Market Capital 132302520.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
UBX Address
UBX
 
UBX Latest News
 
Your Comments and Response on Unity Biotechnology Inc
 
UBX Business Profile
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate include UBX1325, which is Phase I clinical trial for the treatment of age-related diseases of the eye, including age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. It is also developing UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California. Address: 285 East Grand Avenue, South San Francisco, CA, United States, 94080
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service